Skip to main content
SpringerLink
Log in

Atypische Neuroleptika doch von Vorteil

  • aktuell
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

Erste Ergebnisse einer Industrie-unabhängigen Studie bestätigen: Moderne Antipsychotika verbessern die Lebensqualität.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Symposium „Industrieunabhängige Psychopharmakastudien in der Bundesrepublik Deutschland“; DGPPN-Kongress, Berlin, 29.11.2013

Download references

Author information

Authors and Affiliations

  1. Springer Medizin, Berlin, Deutschland

    Thomas Müller

Authors
  1. Thomas Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, T. Atypische Neuroleptika doch von Vorteil. InFo Neurologie 15, 52–53 (2013). https://doi.org/10.1007/s15005-013-0699-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-013-0699-9

Search

Navigation